Elite Pharmaceuticals (ELTP) Other Non-Current Assets (2011 - 2026)
Elite Pharmaceuticals (ELTP) posted Other Non-Current Assets of $567,422 for fiscal Q1 2027 (quarter ended Jun 30, 2026), up 3.1% from $550,299 a year earlier and up 0.7% from the prior quarter.
Powered by 
Analysis
Elite Pharmaceuticals (ELTP) Other Non-Current Assets (2011 - 2026) Analysis & Trends
At the end of FY2026 (ended Mar 31, 2026), Elite Pharmaceuticals' Other Non-Current Assets came in at $563,501, up 3.3% from FY2025.
- Annual Other Non-Current Assets has increased for three consecutive fiscal years, with a five-year compound annual growth rate of 2.6% (FY2021 to FY2026).
- In prior fiscal years, Elite Pharmaceuticals' Other Non-Current Assets was $545,757 in FY2025 (+3.5%), $527,072 in FY2024 (+21.6%), $433,452 in FY2023 (-12.7%) and $496,777 in FY2022 (unchanged).
- Quarterly Other Non-Current Assets has run from a low of $405,164 in fiscal Q3 2023 to a high of $910,767 in fiscal Q3 2025 over five years.
- On a year-over-year basis, Other Non-Current Assets increased in seven of the last eight quarters, with growth averaging 14.9%.
- The strongest year-over-year quarter for Other Non-Current Assets in the past five years was fiscal Q3 2025, with growth of 109.2%; the weakest was fiscal Q3 2023, with a decline of 47.4%.
- According to Business Quant data, Other Non-Current Assets for the three prior fiscal quarters was $563,501 (Q4 2026), $559,556 (Q3 2026) and $610,926 (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 7.48 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 14.27 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 10.73 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 19.60 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 5.93 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | - |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 12.98 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 4.75 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 9.94 Bn |
| 10 | Elite Pharmaceuticals | 268.12 Mn | 149.80 Mn | 13.51 Mn | 567,422.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 567,422.00 |
| Mar 31, 2026 | 563,501.00 |
| Dec 31, 2025 | 559,556.00 |
| Sep 30, 2025 | 610,926.00 |
| Jun 30, 2025 | 550,299.00 |
| Mar 31, 2025 | 545,757.00 |
| Dec 31, 2024 | 910,767.00 |
| Sep 30, 2024 | 543,364.00 |
| Jun 30, 2024 | 532,462.00 |
| Mar 31, 2024 | 527,072.00 |
| Dec 31, 2023 | 435,258.00 |
| Sep 30, 2023 | 443,768.00 |
| Jun 30, 2023 | 436,448.00 |
| Mar 31, 2023 | 433,452.00 |
| Dec 31, 2022 | 405,164.00 |
| Sep 30, 2022 | 496,902.00 |
| Mar 31, 2022 | 496,777.00 |
| Dec 31, 2021 | 769,590.00 |
| Sep 30, 2021 | 769,582.00 |
| Jun 30, 2021 | 496,751.00 |
API Access
Elite Pharmaceuticals Other Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=ELTP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-assets", "ticker": "ELTP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=ELTP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();